T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.74B |
| 2 |
Charles Schwab
SCHW
|
$1.49B |
| 3 |
Amazon
AMZN
|
$1.26B |
| 4 |
Lam Research
LRCX
|
$1.05B |
| 5 |
Las Vegas Sands
LVS
|
$1.01B |
Top Sells
| 1 |
Yum! Brands
YUM
|
$1.31B |
| 2 |
Apple
AAPL
|
$1.29B |
| 3 |
Tesla
TSLA
|
$1.27B |
| 4 |
JPMorgan Chase
JPM
|
$1.06B |
| 5 |
Morgan Stanley
MS
|
$997M |
Sector Composition
| 1 | Technology | 16.94% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 15.14% |
| 5 | Communication Services | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HDS
201
DELISTED
HD Supply Holdings, Inc.
HDS
| $687M | 0.11% |
16,024,469
+163,457
| +1% | +$7.01M |
|
202
Verisk Analytics
VRSK
$37.8B
| $686M | 0.1% |
6,377,135
-125,368
| -2% | -$13.5M |
|
|
CTLT
203
DELISTED
CATALENT, INC.
CTLT
| $686M | 0.1% |
16,366,611
+309,312
| +2% | +$13M |
|
204
Sherwin-Williams
SHW
$92.9B
| $683M | 0.1% |
5,026,440
+726,057
| +17% | +$98.6M |
|
205
Wabtec
WAB
$33B
| $681M | 0.1% |
6,906,811
+1,207,596
| +21% | +$119M |
|
206
GSK
GSK
$81.5B
| $672M | 0.1% |
13,341,466
+172,419
| +1% | +$8.69M |
|
207
Accenture
ACN
$159B
| $669M | 0.1% |
4,092,345
+91,479
| +2% | +$15M |
|
208
Allegion
ALLE
$14.8B
| $669M | 0.1% |
8,641,636
+2,482,078
| +40% | +$192M |
|
209
Atmos Energy
ATO
$26.7B
| $665M | 0.1% |
7,382,475
-290,740
| -4% | -$26.2M |
|
210
Entergy
ETR
$39.2B
| $659M | 0.1% |
16,302,392
+6,990,042
| +75% | +$282M |
|
211
EQT Corp
EQT
$32.2B
| $658M | 0.1% |
21,915,823
+1,289,127
| +6% | +$38.7M |
|
212
Charter Communications
CHTR
$35.7B
| $658M | 0.1% |
2,243,403
+971,234
| +76% | +$285M |
|
213
Bank of America
BAC
$369B
| $638M | 0.1% |
22,649,229
-16,706,081
| -42% | -$471M |
|
|
CLGX
214
DELISTED
Corelogic, Inc.
CLGX
| $635M | 0.1% |
12,242,034
+635,512
| +5% | +$33M |
|
215
United Airlines
UAL
$34.5B
| $601M | 0.09% |
8,614,245
+430,403
| +5% | +$30M |
|
216
S&P Global
SPGI
$164B
| $599M | 0.09% |
2,938,864
-105,526
| -3% | -$21.5M |
|
217
Rayonier
RYN
$4.12B
| $598M | 0.09% |
16,248,376
-6,426,220
| -28% | -$237M |
|
218
Canadian Natural Resources
CNQ
$63.2B
| $598M | 0.09% |
33,854,976
+983,007
| +3% | +$17.4M |
|
219
Phillips 66
PSX
$53.2B
| $596M | 0.09% |
5,304,402
+4,587,253
| +640% | +$515M |
|
220
Sarepta Therapeutics
SRPT
$1.96B
| $594M | 0.09% |
4,495,963
+1,097,796
| +32% | +$145M |
|
221
Webster Financial
WBS
$10.3B
| $590M | 0.09% |
9,254,663
-205,841
| -2% | -$13.1M |
|
222
Franklin Resources
BEN
$13B
| $588M | 0.09% |
18,335,331
+10,350,694
| +130% | +$332M |
|
223
Bristol-Myers Squibb
BMY
$96B
| $587M | 0.09% |
10,609,357
-258,159
| -2% | -$14.3M |
|
224
Neurocrine Biosciences
NBIX
$14.3B
| $583M | 0.09% |
5,930,307
-334,357
| -5% | -$32.8M |
|
225
Biogen
BIIB
$20.6B
| $573M | 0.09% |
1,973,631
-2,048,468
| -51% | -$595M |
|